Showing results (1561-1570 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|July 7, 2021
Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised SeizuresEugen Trinka, Simona Lattanzi, Kate Carpenter, et al.CNS Drugs|January 4, 2020
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple SclerosisDamiano Paolicelli, Alessia Manni, Antonio Iaffaldano, et al.CNS Drugs|May 6, 2022
Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway InhibitorsJeffrey S Wefel, Charles J Ryan, Julie Van, et al.CNS Drugs|July 13, 2022
Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with SchizophreniaTanja Veselinović, Irene NeunerCNS Drugs|October 14, 2021
Amantadine Revisited: A Contender for Initial Treatment in Parkinson's Disease?Sarah Marmol, Matthew Feldman, Carlos Singer, et al.CNS Drugs|July 28, 2010
Low-dose doxepin: in the treatment of insomniaJuliane Weber, M Asif A Siddiqui, Antona J Wagstaff, et al.CNS Drugs|November 25, 2010
Epidemiology and management of alcohol dependence in individuals with post-traumatic stress disorderElissa McCarthy, Ismene PetrakisCNS Drugs|November 25, 2010
Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorderJames C Ermer, Ben A Adeyi, Michael L PucciCNS Drugs|September 3, 2010
Role of zinc in the pathogenesis of attention-deficit hyperactivity disorder: implications for research and treatmentPeter Lepping, Markus HuberPageof 211